Florence Capo

Florence Capo

Auto-generated profile, based on publicly available information

Florence Capo

Department of Microbiology and Immunology, IWK Research Centre, Dalhousie University, 5850/5980 University Avenue, Halifax, NS B3K 6R8, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in Microorganisms
Verified
Journal Article
Open access
PDF file
FCFlorence Capo
Florence Capo
AWAlexa Wilson
Alexa Wilson
FCFrancesca Di Cara
Francesca Di Cara
In all metazoans, the intestinal tract is an essential organ to integrate nutritional signaling, hormonal cues and immunometabolic networks. The dysregulation of intestinal epithelium functions can impact organism physiology and, in humans, leads to devastating and complex diseases, such as inflammatory bowel diseases, intestinal cancers, and obesity. Two decades ago, the discovery of an immune response in the intestine of the genetic model system, Drosophila melanogaster, sparked interest in using this model organism to dissect the mechanisms that govern gut (patho) physiology in humans. In 2007, the finding of the intestinal stem cell lineage, followed by the development of tools available for its manipulation in vivo, helped to elucidate the structural organization and functions of the fly intestine and its similarity with mammalian gastrointestinal systems. To date, studies of the Drosophila gut have already helped to shed light on a broad range of biological questions regarding stem cells and their niches, interorgan communication, immunity and immunometabolism, making the Drosophila a promising model organism for human enteric studies. This review summarizes our current knowledge of the structure and functions of the Drosophila melanogaster intestine, asserting its validity as an emerging model system to study gut physiology, regeneration, immune defenses and host-microbiota interactions.

1 February 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
BCBernard Charroux
Bernard Charroux
FCFlorence Capo
Florence Capo
CKC. Léopold Kurz
C. Léopold Kurz
SPSabine Peslier
Sabine Peslier
DCDelphine Chaduli
Delphine Chaduli
JRJulien Royet
Julien Royet

31 March 2015 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
MSMarion Seillier
Marion Seillier
LPLaurent Pouyet
Laurent Pouyet
PNPrudence N'GUessan
Prudence N'GUessan
MNMarie Nollet
Marie Nollet
FCFlorence Capo
Florence Capo
ACAlice Carrier
Alice Carrier
The metabolic syndrome covers metabolic abnormalities including obesity and type 2 diabetes (T2D). T2D is characterized by insulin resistance resulting from both environmental and genetic factors. A genome‐wide association study (GWAS) published in 2010 identified TP53INP1 as a new T2D susceptibility locus, but a pathological mechanism was not identified. In this work, we show that mice lacking TP53INP1 are prone to redox‐driven obesity and insulin resistance. Furthermore, we demonstrate that the reactive oxygen species increase in TP53INP1‐deficient cells results from accumulation of defective mitochondria associated with impaired PINK/PARKIN mitophagy. This chronic oxidative stress also favors accumulation of lipid droplets. Taken together, our data provide evidence that the GWAS‐identified TP53INP1 gene prevents metabolic syndrome, through a mechanism involving prevention of oxidative stress by mitochondrial homeostasis regulation. In conclusion, this study highlights TP53INP1 as a molecular regulator of redox‐driven metabolic syndrome and provides a new preclinical mouse model for metabolic syndrome clinical research.

1 November 2016 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
FCFlorence Capo
Florence Capo
BCBernard Charroux
Bernard Charroux
JRJulien Royet
Julien Royet

18 July 2017 in Journal of Innate Immunity
Verified
Journal Article
Open access
PDF file
FCFlorence Capo
Florence Capo
DCDelphine Chaduli
Delphine Chaduli
AVAnnelise Viallat-Lieutaud
Annelise Viallat-Lieutaud
BCBernard Charroux
Bernard Charroux
JRJulien Royet
Julien Royet
Peptidoglycan (PGN) detection by PGN recognition proteins (PGRP) is the main trigger of the antibacterial immune response in Drosophila. Depending on the type of immune cell, PGN can be sensed either at the cell membrane by PGRP-LC or inside the cell by PGRP-LE, which plays a role similar to that of Nod2 in mammals. Previous work, mainly in cell cultures, has shown that oligopeptide transporters of the SLC15 family are essential for the delivery of PGN for Nod2 detection inside of the cells, and that this function might be conserved in flies. By generating and analyzing the immune phenotypes of loss-of-function mutations in 3 SLC15 Drosophila family members, we tested their role in mediating PGRP-LE-dependent PGN activation. Our results show that Yin, CG2930, and CG9444 are required neither for PGRP-LE activation by PGN nor for PGN transport from the gut lumen to the insect blood. These data show that, while intracellular PGN detection is an essential step of the antibacterial response in both insects and mammals, the types of PGN transporters and sensors are different in these animals.

2 April 2026
Verified
Thesis
Closed access
FCFlorence Capo
Florence Capo
Les interactions cellules épithéliales-bactéries peuvent conduire à l'établissement d'une tolérance vis-à-vis des bactéries commensales ou à l’élimination des bactéries pathogènes par le système immunitaire. La détection des bactéries est une étape indispensable à l’orientation de cette réponse. Contrairement aux mammifères, la reconnaissance des bactéries chez la drosophile repose principalement sur la détection d’un composant de la paroi bactérienne, le peptidoglycane (PG), par une famille de récepteurs, les "PeptidoGlycan Recognition Receptors" (PGRPs). Chez la drosophile, le PG des bactéries intestinales extracellulaires peut pénétrer dans les entérocytes et aussi traverser l’épithélium intestinal. Dans l’intestin la détection du PG est régionalisée, elle implique en fonction des domaines deux récepteurs PGRPs distincts (PGRP-LC et PGRP-LE). L'activation de ces PGRPs déclenche une même voie de signalisation NF-kB et conduit à la production de peptides antimicrobiens. La sur-activation de cette voie peut être néfaste pour l'hôte, son intensité est notamment contrôlée par des PGRPs à activité enzymatique qui clivent le PG pour le rendre non immunogène.Au cours de ma thèse, j’ai développé des outils visant à étudier le double mode de détection du PG dans l’intestin. J’ai également testé si les transporteurs de la famille SLC15 étaient impliqués dans le trafic cellulaire du PG. Une partie de ma thèse a aussi été consacrée à préciser le rôle des PGRPs catalytiques dans la réponse immunitaire.